Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study

BACKGROUND: Pioglitazone’s effect on chronic obstructive pulmonary disease (COPD) has rarely been studied. PURPOSE: This retrospective observational study investigated whether the use of pioglitazone would affect the risk of COPD in patients with type 2 diabetes mellitus. PATIENTS AND METHODS: The T...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843794/
https://www.ncbi.nlm.nih.gov/pubmed/35177899
http://dx.doi.org/10.2147/COPD.S345796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843794/
https://www.ncbi.nlm.nih.gov/pubmed/35177899
http://dx.doi.org/10.2147/COPD.S345796

Ejemplares similares